FT Summit: AI and regulatory changes at the forefront of industry’s mind
After a few years of disruption caused by the Covid-19 pandemic, it seems that the pharma and biotech industries can…
All articles by Urtė Fultinavičiūtė
Urtė Fultinavičiūtė
@ufulti
Urtė Fultinavičiūtė is a healthcare reporter for Clinical Trials Arena. Urtė's coverage focuses on clinical data management and clinical strategy. Urtė holds an MA in International Journalism from City, University of London.
-
-
GSK’s RSV vaccine Arexvy effective in adults aged 50-59 years
GSK has released new preliminary data showing that its respiratory syncytial virus (RSV) vaccine Arexvy met primary endpoints in a…
-
Can a nasal spray tackle agitation in autism?
The rate at which children are being identified with autism spectrum disorder (ASD) has tripled in the past two decades.…
-
California’s low-cost insulin plans receive $100m manufacturing boost
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to…
-
Covid-19 vaccines targeting Omicron variants expected to be ready this autumn
As regulatory agencies gear up for another round of Covid-19 vaccine deliberations centered on emerging variants, Moderna has released data…
-
Lilly eyes weight loss arena for diabetes drug tirzepatide after positive data
Close on the heels of a newly-minted label for Type II diabetes (T2D), Eli Lilly is now paving the way…
-
Medication abortion: what to know about its use and access
The US Senate failed to pass the Women's Health Protection Act, a bill championed by the Democrats to make access…
-
Cell & gene therapy society establishes working group to tackle Expanded Access misuse
The International Society for Cell and Gene Therapy (ISCT) has formed a working group to address concerns over the misuse…